| | | | | | | | |
(In thousands) | | | 2021 | | | | 2020 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | |
Net earnings | | $ | 279,611 | | | $ | 110,264 | |
Adjustments to reconcile net earnings to net cash from operating activities: | | | | | | | | |
| | | | | | | | |
Depreciation | | | 38,342 | | | | 31,330 | |
Amortization of intangibles | | | 7,193 | | | | 3,129 | |
Expense associated with share-based and grant compensation arrangements | | | 5,742 | | | | 2,303 | |
Deferred income taxes | | | 177 | | | | 290 | |
Unrealized (gain) loss on investment and other | | | (2,784) | | | | 473 | |
Equity in earnings of investee | | | 1,465 | | | | — | |
Net gain on sale and disposition of assets | | | (1,577) | | | | (271) | |
Changes in: | | | | | | | | |
Accounts receivable | | | (336,094) | | | | (155,554) | |
Inventories | | | (329,577) | | | | 25,983 | |
Accounts payable and cash overdraft | | | 143,018 | | | | 57,017 | |
Accrued liabilities and other | | | 78,751 | | | | 72,246 | |
NET CASH (USED IN) FROM OPERATING ACTIVITIES | | | (115,733) | | | | 147,210 | |
| | | | | | | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | |
Purchases of property, plant, and equipment | | | (79,028) | | | | (46,730) | |
Proceeds from sale of property, plant and equipment | | | 6,673 | | | | 644 | |
Acquisitions and purchase of noncontrolling interest, net of cash received | | | (433,239) | | | | (18,689) | |
Purchases of investments | | | (14,581) | | | | (20,094) | |
Proceeds from sale of investments | | | 6,885 | | | | 18,339 | |
Other | | | (708) | | | | 318 | |
NET CASH USED IN INVESTING ACTIVITIES | | | (513,998) | | | | (66,212) | |
| | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | |
Borrowings under revolving credit facilities | | | 849,944 | | | | 6,759 | |
Repayments under revolving credit facilities | | | (589,695) | | | | (6,498) | |
Contingent consideration payment and other | | | (1,464) | | | | (3,077) | |
Proceeds from issuance of common stock | | | 936 | | | | 697 | |
Dividends paid to shareholders | | | (18,550) | | | | (15,374) | |
Distributions to noncontrolling interest | | | (2,914) | | | | (299) | |
Repurchase of common stock | | | — | | | | (29,212) | |
Other | | | (331) | | | | 32 | |
NET CASH FROM (USED IN) FINANCING ACTIVITIES | | | 237,926 | | | | (46,972) | |
| | | | | | | | |
Effect of exchange rate changes on cash | | | 112 | | | | (1,422) | |
NET CHANGE IN CASH AND CASH EQUIVALENTS | | | (391,693) | | | | 32,604 | |
| | | | | | | | |
ALL CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | | | 436,608 | | | | 168,666 | |
| | | | | | | | |
ALL CASH AND CASH EQUIVALENTS, END OF PERIOD | | $ | 44,915 | | | $ | 201,270 | |
| | | | | | | | |
Reconciliation of cash and cash equivalents and restricted cash: | | | | | | | | |
Cash and cash equivalents, beginning of period | | $ | 436,507 | | | $ | 168,336 | |
Restricted cash, beginning of period | | | 101 | | | | 330 | |
All cash and cash equivalents, beginning of period | | $ | 436,608 | | | $ | 168,666 | |
| | | | | | | | |
Cash and cash equivalents, end of period | | $ | 44,286 | | | $ | 200,546 | |
Restricted cash, end of period | | | 629 | | | | 724 | |
All cash and cash equivalents, end of period | | $ | 44,915 | | | $ | 201,270 | |
| | | | | | | | |